Management after first-line antiresorptive treatment for postmenopausal osteoporosis

被引：3
作者：
Paccou, Julien [1 ]
机构：
[1] CHRU Lille, Rheumatol, Hop Roger Salengro, Rue Emile Laine, F-59037 Lille, France
来源：
JOINT BONE SPINE | 2016年 / 83卷 / 04期
关键词：
Bisphosphonates; Denosumab; Osteoporosis; T-score; Fractures; ZOLEDRONIC ACID TREATMENT; FRACTURE; ALENDRONATE; EXTENSION; TRIAL; WOMEN; DENOSUMAB; RISK;
D O I：
10.1016/j.jbspin.2016.02.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 375
页数：3
相关论文
共 50 条
  • [41] Treatment of postmenopausal osteoporosis
    Greenblatt, D
    PHARMACOTHERAPY, 2005, 25 (04): : 574 - 584
  • [42] Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
    Solling, A. S. Koldkjaer
    Harslof, T.
    Langdahl, B.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (05) : 995 - 1002
  • [43] Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis Therapies
    Kobelski, Margaret M.
    Ramchand, Sabashini K.
    Tsai, Joy N.
    Leder, Benjamin Z.
    Demay, Marie B.
    ENDOCRINOLOGY, 2024, 165 (12)
  • [44] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Choo, Y. W.
    Mohd Tahir, N. A.
    Mohamed Said, M. S.
    Li, S. C.
    Makmor Bakry, M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (09) : 1909 - 1923
  • [45] The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
    Szulc, Pawel
    CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 907 - 919
  • [46] Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
    Naylor, K. E.
    Mccloskey, E., V
    Jacques, R. M.
    Peel, N. F. A.
    Paggiosi, M. A.
    Gossiel, F.
    Walsh, J. S.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (04) : 917 - 922
  • [47] Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis
    Roux, C
    Garnero, P
    Thomas, T
    Sabatier, JP
    Orcel, P
    Audran, M
    JOINT BONE SPINE, 2005, 72 (01) : 26 - 31
  • [48] Treatment needs and current options for postmenopausal osteoporosis
    Gennari, Luigi
    Rotatori, Stefano
    Bianciardi, Simone
    Nuti, Ranuccio
    Merlotti, Daniela
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (08) : 1141 - 1152
  • [49] Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
    Lewiecki, E. Michael
    DRUG HEALTHCARE AND PATIENT SAFETY, 2011, 3 : 79 - 91
  • [50] Combination and sequential treatment in women with postmenopausal osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Yavropoulou, Maria P.
    Makras, Polyzois
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (04) : 477 - 490
12345